Were Hedge Funds Right About CymaBay Therapeutics Inc (CBAY)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Cymabay Therapeutics Inc. (CBAY)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Is CBAY A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
CymaBay Therapeutics Inc (CBAY): Hedge Funds Are Snapping Up
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Funds Keep Selling CymaBay Therapeutics Inc (CBAY)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is CymaBay Therapeutics Inc (CBAY) Going To Burn These Hedge Funds ?
How do we determine whether CymaBay Therapeutics Inc (NASDAQ:CBAY) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend...
Hedge Funds Have Never Been This Bullish On CymaBay Therapeutics Inc (CBAY)
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and optimism towards the resolution of the trade war with China...
Hedge Funds Have Never Been This Bullish On CymaBay Therapeutics Inc (CBAY)
Does CymaBay Therapeutics Inc (NASDAQ:CBAY) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company.
Hedge Funds Are Buying CymaBay Therapeutics Inc (CBAY)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don...
13G Filing: Perceptive Advisors and Cymabay Therapeutics Inc. (CBAY)
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...
13G Filing: Foresite Capital Fund III, L.P. and Cymabay Therapeutics Inc. (CBAY)
SOLE VOTING POWER600,000 shares, except that Foresite Capital Management III, LLC (“FCM III”), the general partner of FCF III, may be deemed to have sole power to vote these shares, and James Tananbaum...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
